...
首页> 外文期刊>Liver international >Systematic review with meta‐analysis: Nutritional screening and assessment tools in cirrhosis
【24h】

Systematic review with meta‐analysis: Nutritional screening and assessment tools in cirrhosis

机译:荟萃分析的系统评价:肝硬化的营养筛查和评估工具

获取原文
获取原文并翻译 | 示例

摘要

Abstract Background amp; Aims Disease‐related malnutrition is common in cirrhosis. Multiple studies have evaluated nutritional screening tools (NSTs, rapid bedside tests targeting who needs assessment) and nutritional assessment tools (NATs, used in diagnosing malnutrition) as predictors of clinical outcome in this population. We performed a systematic review and meta‐analysis of this literature with the aim of summarising the varying definitions of malnutrition across studies, the available evidence for NSTs and the ability of NSTs and NATs to predict clinical outcomes in cirrhosis. Methods The primary outcome measures were pre‐ and post‐transplant mortality with a range of secondary outcomes. Inclusion: cirrhosis over age 16. Exclusion: 25 with hepatocellular carcinoma, primarily laboratory test‐based NATs or lack of screening, assessment or outcome criteria. Results Eight thousand eight hundred fifty patients were included across 47 studies. Only 3 studies assessed NSTs. Thirty‐two definitions for malnutrition were utilised across studies. NATs predicted pre‐transplant mortality in 69 of cases that were assessed with a risk ratio (RR) of 2.38 (95 CI 1.96‐2.89). NATs were prognostic for post‐transplant mortality only 28 of the times they were assessed, with a RR of 3.04 (95 CI 1.51‐6.12). Conclusions The cirrhosis literature includes limited data on nutrition screening and multiple definitions for what constitutes malnutrition using NATs. Despite this discordance, it is clear that malnutrition is a valuable predictor of pre‐transplant mortality almost regardless of how it is defined. We require clinical and research consensus around the definition of malnutrition and the accepted processes and cut‐points for nutrition screening and assessment in cirrhosis.
机译:摘要 背景和目的 疾病相关的营养不良在肝硬化中很常见。多项研究评估了营养筛查工具(NSTs,针对需要评估的人的快速床边检测)和营养评估工具(NAT,用于诊断营养不良)作为该人群临床结局的预测因子。我们对这些文献进行了系统评价和荟萃分析,旨在总结不同研究对营养不良的不同定义、NSTs的现有证据以及NSTs和NATs预测肝硬化临床结局的能力。方法 主要结局指标是移植前和移植后死亡率,以及一系列次要结局。包括:16 岁以上的肝硬化。排除:>25% 患有肝细胞癌,主要是基于实验室检查的 NAT 或缺乏筛查、评估或结局标准。结果 47项研究共纳入8850例患者。只有3项研究评估了NSTs,所有研究都使用了32项营养不良的定义。NATs预测了69%的病例的移植前死亡率,这些病例的风险比(RR)为2.38(95%CI 1.96-2.89)。NATs在评估期间仅对移植后死亡率有28%的预后,RR为3.04(95%CI 1.51-6.12)。结论 肝硬化文献中关于营养筛查的数据有限,以及使用NATs对营养不良构成的多种定义。尽管存在这种不一致,但很明显,无论如何定义,营养不良都是移植前死亡率的重要预测指标。我们需要围绕营养不良的定义以及肝硬化营养筛查和评估的公认过程和切点达成临床和研究共识。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号